Structural Basis of the Modulation of the Voltage-Gated Calcium Ion Channel Ca 1.1 by Dihydropyridine Compounds*

Overview

Journal Angew Chem Int Ed Engl

Specialty Chemistry

Date 2020 Oct 30

PMID 33125829

Citations 35

Authors

Shuai Gao

Nieng Yan

Affiliations

Soon will be listed here.

Abstract

1,4-Dihydropyridines (DHP), the most commonly used antihypertensives, function by inhibiting the L-type voltage-gated Ca (Ca ) channels. DHP compounds exhibit chirality-specific antagonistic or agonistic effects. The structure of rabbit Ca 1.1 bound to an achiral drug nifedipine reveals the general binding mode for DHP drugs, but the molecular basis for chiral specificity remained elusive. Herein, we report five cryo-EM structures of nanodisc-embedded Ca 1.1 in the presence of the bestselling drug amlodipine, a DHP antagonist (R)-(+)-Bay K8644, and a titration of its agonistic enantiomer (S)-(-)-Bay K8644 at resolutions of 2.9-3.4 Å. The amlodipine-bound structure reveals the molecular basis for the high efficacy of the drug. All structures with the addition of the Bay K8644 enantiomers exhibit similar inactivated conformations, suggesting that (S)-(-)-Bay K8644, when acting as an agonist, is insufficient to lock the activated state of the channel for a prolonged duration.

Citing Articles

- Simplifying the Complex: Building, Simulating, and Analyzing Protein-Ligand Systems in .

Talagayev V, Chen Y, Doering N, Obendorf L, Denzinger K, Puls K J Chem Inf Model. 2025; 65(4):1967-1978.

PMID: 39933881 PMC: 11863370. DOI: 10.1021/acs.jcim.4c02158.

Inactivation of CaV1 and CaV2 channels.

Limpitikul W, Dick I J Gen Physiol. 2025; 157(2).

PMID: 39883005 PMC: 11781272. DOI: 10.1085/jgp.202313531.

C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models.

Tang C, Gomez K, Chen Y, Allen H, Hestehave S, Rodriguez-Palma E J Clin Invest. 2024; 135(4).

PMID: 39656529 PMC: 11827853. DOI: 10.1172/JCI177429.

Molecular Insights into Single Chain Lipid Modulation of Acid-Sensing Ion Channel 3.

Bandarupalli R, Roth R, Klipp R, Bankston J, Li J bioRxiv. 2024; .

PMID: 39257759 PMC: 11383688. DOI: 10.1101/2024.08.29.610156.

Establishing the Thermodynamic Cards of Dipine Models' Oxidative Metabolism on 21 Potential Elementary Steps.

Shen G, Gao S, Jia Y, Zhu X, Qian B Molecules. 2024; 29(15).

PMID: 39125109 PMC: 11313972. DOI: 10.3390/molecules29153706.

References

Shen H, Zhou Q, Pan X, Li Z, Wu J, Yan N . Structure of a eukaryotic voltage-gated sodium channel at near-atomic resolution. Science. 2017; 355(6328). DOI: 10.1126/science.aal4326. View

Clapham D . Calcium signaling. Cell. 2007; 131(6):1047-58. DOI: 10.1016/j.cell.2007.11.028. View

NAYLER W, Gu X . (-)[3H]amlodipine binding to rat cardiac membranes. J Cardiovasc Pharmacol. 1991; 17(4):587-92. DOI: 10.1097/00005344-199104000-00010. View

Nowycky M, Fox A, Tsien R . Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature. 1985; 316(6027):440-3. DOI: 10.1038/316440a0. View

Zhao Y, Huang G, Wu J, Wu Q, Gao S, Yan Z . Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca Channel. Cell. 2019; 177(6):1495-1506.e12. DOI: 10.1016/j.cell.2019.04.043. View

Yan Z, Zhou Q, Wang L, Wu J, Zhao Y, Huang G . Structure of the Na1.4-β1 Complex from Electric Eel. Cell. 2017; 170(3):470-482.e11. DOI: 10.1016/j.cell.2017.06.039. View

AFFOLTER H, Coronado R . Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules. Biophys J. 1985; 48(2):341-7. PMC: 1329327. DOI: 10.1016/S0006-3495(85)83789-9. View

Bechem M, Schramm M . Calcium-agonists. J Mol Cell Cardiol. 1987; 19 Suppl 2:63-75. DOI: 10.1016/s0022-2828(87)80005-6. View

Aparisi Rey A, Purrio M, Viveros M, Lutz B . Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology. 2012; 37(12):2624-34. PMC: 3473327. DOI: 10.1038/npp.2012.123. View

10.

Monti J, Hawkins M, Jantos H, DAngelo L, Fernandez M . Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology (Berl). 1988; 95(3):395-400. DOI: 10.1007/BF00181955. View

11.

Zamponi G, Striessnig J, Koschak A, Dolphin A . The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacol Rev. 2015; 67(4):821-70. PMC: 4630564. DOI: 10.1124/pr.114.009654. View

12.

Ertel E, Campbell K, Harpold M, Hofmann F, Mori Y, Perez-Reyes E . Nomenclature of voltage-gated calcium channels. Neuron. 2000; 25(3):533-5. DOI: 10.1016/s0896-6273(00)81057-0. View

13.

Arrowsmith J, Campbell S, Cross P, Stubbs J, Burges R, Gardiner D . Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. J Med Chem. 1986; 29(9):1696-702. DOI: 10.1021/jm00159a022. View

14.

Sorkin E, Clissold S, Brogden R . Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. Drugs. 1985; 30(3):182-274. DOI: 10.2165/00003495-198530030-00002. View

15.

Dolphin A . A short history of voltage-gated calcium channels. Br J Pharmacol. 2006; 147 Suppl 1:S56-62. PMC: 1760727. DOI: 10.1038/sj.bjp.0706442. View

16.

Peterson B, Tanada T, Catterall W . Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels. J Biol Chem. 1996; 271(10):5293-6. DOI: 10.1074/jbc.271.10.5293. View

17.

Dube G, Baik Y, Schwartz A . Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine. J Cardiovasc Pharmacol. 1985; 7(2):377-89. DOI: 10.1097/00005344-198503000-00025. View

18.

Bechem M, Hoffmann H . The molecular mode of action of the Ca agonist (-) BAY K 8644 on the cardiac Ca channel. Pflugers Arch. 1993; 424(3-4):343-53. DOI: 10.1007/BF00384362. View

19.

Schramm M, Thomas G, Towart R, Franckowiak G . Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature. 1983; 303(5917):535-7. DOI: 10.1038/303535a0. View

20.

Mason R, Campbell S, Wang S, Herbette L . Comparison of location and binding for the positively charged 1,4-dihydropyridine calcium channel antagonist amlodipine with uncharged drugs of this class in cardiac membranes. Mol Pharmacol. 1989; 36(4):634-40. View